Parkinson's disease other imaging findings: Difference between revisions
No edit summary |
|||
| Line 15: | Line 15: | ||
<br clear="left" /> | <br clear="left" /> | ||
'''DaTscan''': This technique can help us differentiate healthy individuals or patients with essential tremor from diseases with nigrostriatal degeneration (PD, MSA, PSP, and cortical degeneration). | '''DaTscan''': This technique can help us differentiate healthy individuals or patients with essential tremor from diseases with nigrostriatal degeneration (PD, MSA, PSP, and cortical degeneration).<ref name="pmid22014434">{{cite journal |vauthors=Stoessl AJ, Martin WW, McKeown MJ, Sossi V |title=Advances in imaging in Parkinson's disease |journal=Lancet Neurol |volume=10 |issue=11 |pages=987–1001 |date=November 2011 |pmid=22014434 |doi=10.1016/S1474-4422(11)70214-9 |url=}}</ref><ref name="pmid20019219">{{cite journal |vauthors=Kägi G, Bhatia KP, Tolosa E |title=The role of DAT-SPECT in movement disorders |journal=J. Neurol. Neurosurg. Psychiatry |volume=81 |issue=1 |pages=5–12 |date=January 2010 |pmid=20019219 |doi=10.1136/jnnp.2008.157370 |url=}}</ref> | ||
==References== | ==References== | ||
Revision as of 07:21, 18 April 2018
|
Parkinson's disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Parkinson's disease other imaging findings On the Web |
|
American Roentgen Ray Society Images of Parkinson's disease other imaging findings |
|
Risk calculators and risk factors for Parkinson's disease other imaging findings |
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Other Imaging Findings
PET scan: In PET scan we can see that the uptake of [18F]-flurodopa tracer in reduce in the caudate and putamen in PD patients.[1]
DaTscan: This technique can help us differentiate healthy individuals or patients with essential tremor from diseases with nigrostriatal degeneration (PD, MSA, PSP, and cortical degeneration).[2][3]
References
- ↑ Teune LK, Bartels AL, de Jong BM, Willemsen AT, Eshuis SA, de Vries JJ, van Oostrom JC, Leenders KL (October 2010). "Typical cerebral metabolic patterns in neurodegenerative brain diseases". Mov. Disord. 25 (14): 2395–404. doi:10.1002/mds.23291. PMID 20669302.
- ↑ Stoessl AJ, Martin WW, McKeown MJ, Sossi V (November 2011). "Advances in imaging in Parkinson's disease". Lancet Neurol. 10 (11): 987–1001. doi:10.1016/S1474-4422(11)70214-9. PMID 22014434.
- ↑ Kägi G, Bhatia KP, Tolosa E (January 2010). "The role of DAT-SPECT in movement disorders". J. Neurol. Neurosurg. Psychiatry. 81 (1): 5–12. doi:10.1136/jnnp.2008.157370. PMID 20019219.